Health ❯ Obesity ❯ Chronic Diseases

Weight Management

Pharmaceutical Treatments Pharmaceutical Interventions GLP-1 Medications Clinical Trials

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

The once-daily pill offers a needle-free alternative to injectables, with a U.S. decision anticipated in early 2026.